Microbot Medical (MBOT) said Monday it plans to sell about 6.1 million shares at $2.13 apiece in a registered direct offering and 12.2 million shares at the same price in a concurrent private placement.
The offerings are expected to close by Tuesday, the company said.
Gross proceeds from these offerings are estimated at about $13 million. The plans to use net proceeds to advance its Liberty Robotic System, explore new applications based on its intellectual properties, and support working capital and general corporate needs, it added.
Shares of the company were down over 18% in recent trading.
Price: 2.09, Change: -0.47, Percent Change: -18.24
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。